Iezza M.; Cortesi S.; Ottaviani E.; Mancini M.; Venturi C.; Monaldi C.; De Santis S.; Testoni N.; Soverini S.; Rosti G.; Cavo M.; Castagnetti F., Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights, «CELLS», 2023, 12, Article number: 1703, pp. 1703 - 1727 [articolo]Open Access
Mancini M.; Monaldi C.; De Santis S.; Papayannidis C.; Rondoni M.; Sartor C.; Bruno S.; Pagano L.; Criscuolo M.; Zanotti R.; Bonifacio M.; Tosi P.; Arock M.; Valent P.; Cavo M.; Soverini S., SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted, «BIOMARKER RESEARCH», 2023, 11, Article number: 29, pp. 29 - 41 [articolo]Open Access
de Santis S.; Monaldi C.; Martelli M.; Mancini M.; Bruno S.; Castagnetti F.; Gugliotta G.; Polakova K.M.; Ernst T.; Maar D.; Corner A.; Cavo M.; Soverini S., CML-184 A Novel Droplet Digital PCR Strategy for Rapid and Sensitive Detection of BCR::ABL1 Kinase Domain Mutations Conferring Resistance to Second-Generation Tyrosine Kinase Inhibitors, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2022, 22, pp. 289 - 290 [articolo]
Mancini M.; Monaldi C.; De Santis S.; Rondoni M.; Papayannidis C.; Sartor C.; Curti A.; Bruno S.; Cavo M.; Soverini S., Combined Inhibition of Polo-like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells, «CANCERS», 2022, 14, pp. 738 - 750 [articolo]Open Access
Soverini S.; De Santis S.; Martelli M.; Monaldi C.; Castagnetti F.; Gugliotta G.; Papayannidis C.; Mancini M.; Bruno S.; Venturi C.; Machova Polakova K.; Ernst T.; Maar D.; Corner A.; Cavo M., Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia, «LEUKEMIA», 2022, 36, pp. 2250 - 2260 [articolo]
Monaldi C.; de Santis S.; Mancini M.; Papayannidis C.; Sartor C.; Rondoni M.; Bruno S.; Cavo M.; Soverini S., MPN-182 Droplet Digital PCR for Non-Invasive Detection of the KIT D816V Mutation in the Peripheral Blood of Patients With Suspected Systemic Mastocytosis, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2022, 22, pp. S328 - S328 [articolo]
De Santis S.; Monaldi C.; Mancini M.; Bruno S.; Cavo M.; Soverini S., Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia, «ONCOTARGETS AND THERAPY», 2022, 15, pp. 103 - 116 [articolo]Open Access
Mancini M.; De Santis S.; Monaldi C.; Castagnetti F.; Lonetti A.; Bruno S.; Dan E.; Sinigaglia B.; Rosti G.; Cavo M.; Gugliotta G.; Soverini S., Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors, «FRONTIERS IN ONCOLOGY», 2022, 12, Article number: 901132, pp. 1 - 13 [articolo]Open Access
Bruno S.; Bandini L.; Patuelli A.; Robustelli V.; Venturi C.; Mancini M.; Forte D.; De Santis S.; Monaldi C.; Grassi A.; Chiurumbolo G.; Paolini S.; Cristiano G.; Papayannidis C.; Sartor C.; Nanni J.; Ottaviani E.; Curti A.; Cavo M.; Soverini S., Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia, «FRONTIERS IN ONCOLOGY», 2021, 11, Article number: 728613, pp. 728613 - 728619 [articolo]Open Access
Soverini S.; De Santis S.; Monaldi C.; Bruno S.; Mancini M., Targeting leukemic stem cells in chronic myeloid leukemia: Is it worth the effort?, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2021, 22, pp. 7093 - 7115 [articolo]Open Access
Bruno S.; Mancini M.; De Santis S.; Monaldi C.; Cavo M.; Soverini S., The role of hypoxic bone marrow microenvironment in acute myeloid leukemia and future therapeutic opportunities, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2021, 22, Article number: 6857, pp. 1 - 18 [articolo]Open Access
Mancini, Manuela; De Santis, Sara; Monaldi, Cecilia; Bavaro, Luana; Martelli, Margherita; Gugliotta, Gabriele; Castagnetti, Fausto; Rosti, Gianantonio; Santucci, Maria Alessandra; Martinelli, Giovanni; Cavo, Michele; Soverini, Simona, Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis, «HEMATOLOGICAL ONCOLOGY», 2020, 38, pp. 201 - 203 [articolo]
Martelli M.; Monaldi C.; De Santis S.; Bruno S.; Mancini M.; Cavo M.; Soverini S., Recent advances in the molecular biology of systemic mastocytosis: Implications for diagnosis, prognosis, and therapy, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2020, 21, Article number: 3987, pp. 3987 - 4007 [articolo]Open Access
Mancini M.; De Santis S.; Monaldi C.; Bavaro L.; Martelli M.; Castagnetti F.; Gugliotta G.; Rosti G.; Santucci M.A.; Martinelli G.; Cavo M.; Soverini S., Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors, «JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH», 2019, 38, Article number: 216, pp. 1 - 11 [articolo]Open Access
Manuela Mancini, Cecilia Monaldi, Sara De Santis, Cristina Papayannidis, Michela Rondoni, Maria Chiara Abbenante, Luana Bavaro, Margherita Martelli, Roberta Zanotti, Livio Pagano, Michele Cavo, Peter Valent, Giovanni Martinelli, Simona Soverini, Polo-like Kinase-1 and Aurora Kinase A As Novel Therapeutic Targets in Neoplastic Mast Cells, «BLOOD», 2017, 130, pp. 5290 - 5290 [abstract]
